Orbital radiotherapy is a well-established method of treatment for severe Graves' ophthalmopathy because of its anti-inflammatory and locally immunosuppressive effects. It has been used for 60 years. Conventional external x-ray and cobalt therapy have been abandoned and most groups now use supervoltage linear accelerators (4-6 MeV). Cumulative doses may vary but in most studies a cumulative dose of 20 Gy delivered over 2 weeks was utilized. Successful outcome depends on the selection of patients because recent onset active ophthalmopathy is much more favorably affected than longstanding inactive disease. Inflammatory signs recent onset eye muscle dysfunction and optic neuropathy respond well to orbital radiotherapy while proptosis and longstanding eye muscle restriction respond poorly. Overall favorable responses have been reported with few exceptions in approximately 60% of cases. Combination of irradiation with high-dose systemic glucocorticoids provides better results than either treatment alone. Orbital radiotherapy is well tolerated and safe. Preexisting retinopathy (e.g. in patients with diabetes) is a contraindication to this treatment for the risk of further retinal damage. No case of radiation-induced tumors has so far been described after orbital radiotherapy for Graves' ophthalmopathy.

Orbital radiotherapy for Graves' ophthalmopathy

BARTALENA, LUIGI;TANDA, MARIA LAURA PIERA;
2002-01-01

Abstract

Orbital radiotherapy is a well-established method of treatment for severe Graves' ophthalmopathy because of its anti-inflammatory and locally immunosuppressive effects. It has been used for 60 years. Conventional external x-ray and cobalt therapy have been abandoned and most groups now use supervoltage linear accelerators (4-6 MeV). Cumulative doses may vary but in most studies a cumulative dose of 20 Gy delivered over 2 weeks was utilized. Successful outcome depends on the selection of patients because recent onset active ophthalmopathy is much more favorably affected than longstanding inactive disease. Inflammatory signs recent onset eye muscle dysfunction and optic neuropathy respond well to orbital radiotherapy while proptosis and longstanding eye muscle restriction respond poorly. Overall favorable responses have been reported with few exceptions in approximately 60% of cases. Combination of irradiation with high-dose systemic glucocorticoids provides better results than either treatment alone. Orbital radiotherapy is well tolerated and safe. Preexisting retinopathy (e.g. in patients with diabetes) is a contraindication to this treatment for the risk of further retinal damage. No case of radiation-induced tumors has so far been described after orbital radiotherapy for Graves' ophthalmopathy.
2002
Bartalena, Luigi; Marcocci, C; Tanda, MARIA LAURA PIERA; Rocchi, R; Mazzi, B; Barbesino, G; Pinchera, A.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/1490736
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 48
social impact